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ABSTRACT
Background
Annual influenza vaccination of institutional health care workers (HCWs) is advised in most
Western countries, but adherence to this recommendation is generally low. Although
protective effects of this intervention for nursing home patients have been demonstrated in
some clinical trials, the exact relationship between increased vaccine uptake among HCWs and
protection of patients remains unknown owing to variations between study designs, settings,
intensity of influenza seasons, and failure to control all effect modifiers. Therefore, we use a
mathematical model to estimate the effects of HCW vaccination in different scenarios and to
identify a herd immunity threshold in a nursing home department.
Methods and Findings
We use a stochastic individual-based model with discrete time intervals to simulate influenza
virus transmission in a 30-bed long-term care nursing home department. We simulate different
levels of HCW vaccine uptake and study the effect on influenza virus attack rates among
patients for different institutional and seasonal scenarios. Our model reveals a robust linear
relationship between the number of HCWs vaccinated and the expected number of influenza
virus infections among patients. In a realistic scenario, approximately 60% of influenza virus
infections among patients can be prevented when the HCW vaccination rate increases from 0
to 1. A threshold for herd immunity is not detected. Due to stochastic variations, the differences
in patient attack rates between departments are high and large outbreaks can occur for every
level of HCW vaccine uptake.
Conclusions
The absence of herd immunity in nursing homes implies that vaccination of every additional
HCW protects an additional fraction of patients. Because of large stochastic variations, results of
small-sized clinical trials on the effects of HCW vaccination should be interpreted with great
care. Moreover, the large variations in attack rates should be taken into account when
designing future studies.
The Editors’ Summary of this article follows the references.
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Annual inﬂuenza vaccination of institutional health care
workers (HCWs) is advised in most Western countries to
reduce transmission of inﬂuenza to vulnerable patients [1]. A
few clinical trials have indeed demonstrated protective
effects of this intervention for patients in nursing homes at
relatively low HCW vaccine uptake rates [2–5]. However
adherence to the recommendation is generally low [6–9] and
it is uncertain what the effect of a further increase of vaccine
uptake among HCWs is and whether herd immunity can be
attained in health care institutions [10]. Empirical data from
previous trials did not reveal a clear association between the
number of HCWs vaccinated and the number of prevented
inﬂuenza virus infections in patients. This absence of a clear
association might be due to substantial variation between the
studies in the endpoints measured, the departments (of
varying size) involved, and vaccine coverage among patients.
Furthermore, the effect of HCW vaccination is highly
dependent on annual factors such as inﬂuenza virus activity
and the match between the circulating inﬂuenza virus strain
and the current vaccine. To control for all uncertainties
potentially modifying the effects of HCW vaccination an
exceptionally large clinical trial would be needed.
We, therefore, propose to disentangle the impact of effect
modiﬁers with a mathematical model that can simulate the
occurrence of inﬂuenza virus infections in a nursing home
department under various vaccination and institutional
scenarios. With the model we aim to elucidate the relation-
ship between HCW vaccination and patient attack rates for a
given department size, vaccine uptake among patients, and
vaccine efﬁcacy. Furthermore, we explore whether herd
immunity can be expected to occur in a nursing home at
higher levels of HCW vaccine uptake.
Methods
Population and Model
We simulate the occurrence of inﬂuenza virus outbreaks in
a typical Dutch long-term care nursing home department
with 30 beds (in 15 two-bed rooms) and a team of 30 HCWs.
We assume the 30 HCWs work in shifts of 8 h according to a
weekly schedule, with ﬁve HCWs working during the day shift,
three during the evening, and one during the night. As we are
simulating a small population where chance events can have
major effects we use a stochastic transmission model. Below
we describe the essential structure of this model; a detailed
description is presented in the Text S1.
Infection Cycle
According to a standard model for infectious disease
transmission, individuals can be in one of several stages of
inﬂuenza virus infection: susceptible, infected but not yet
infectious (exposed), infectious, or recovered/immune (S, E, I,
or R) [11,12]. Susceptible individuals can be infected and
become exposed through contact with infectious individuals
from either inside or outside the department. After a latent
period the exposed individuals become infectious and can
infect others until they recover and become immune.
Individuals acquire immunity either by recovery after
infection or by vaccination prior to the inﬂuenza season,
and immune individuals do not return to the susceptible pool
for the remaining season.
Influenza Vaccination
Both patients and HCWs can receive inﬂuenza vaccine
prior to the inﬂuenza season. We assume vaccination leads to
perfect immunity against infection in a fraction ve1 of
vaccinated patients and ve2 of vaccinated HCWs, where ve1
and ve2 are the vaccine efﬁcacies in the corresponding
populations. In the remaining (1  vei) vaccinated individuals
the vaccine has no effect. In Text S1 (Figure IX) we show that
an alternative assumption (vaccination reduces the proba-
bility of becoming infected for all vaccinated individuals, but
does not lead to complete immunity) leads to qualitatively
similar results.
Contacts
As described above, susceptible individuals can become
infected through contacts with infectious individuals. There-
fore, an individual’s risk of being infected depends on the
frequency of contacts that are made, and the likelihood that
the contacted persons are infectious. The number of
potential contacts of patients and HCWs varies per shift
(day, evening, night). Patients can have contact with other
patients, HCWs, and visitors during day and evening shifts.
During night shifts, patients can only contact their roommate
and HCWs. HCWs can have contacts with other HCWs
working in the same shift and with all patients. We distinguish
between casual and close contacts. Individuals have a casual
contact when they have a conversation, and a close contact
when physical contact is present. We parameterize the
contact model such that the expected numbers of contacts,
speciﬁed by type of individuals and kind of contact, matches
the number of contacts that we observed in two nursing home
departments in the Netherlands (Text S1 [Tables III–V]).
Transmission
The occurrence of transmission between contacts is
modeled by sampling from a Bernoulli distribution with
mean set equal to the transmission probability. For every pair
of individuals with a casual or close contact, there is a
probability p1 or p2, respectively, that the virus is transmitted
if the individuals involved in the contact are infectious and
susceptible. We take p2 always larger than p1 to reﬂect that
transmission is more likely for close contacts than for casual
contacts.
Influenza in the Community
The rate at which inﬂuenza virus is introduced into the
nursing home by HCWs, visitors, and patients depends on the
prevalence of the virus in the community. We simulate an
inﬂuenza epidemic in a large population (the community)
with a deterministic SIR model (see Text S1 [Figure I]), and
use the associated daily incidence and prevalence rates in our
nursing home model. HCWs are assumed to have many
contacts in the community and the hazard rate of becoming
infected outside the nursing home is equal to the hazard rate
of infection in the community. Visitors and new patients are
chosen at random from the community and the probability
that they are infected when they enter the nursing home is
equal to the community prevalence.
Parameters and Uncertainty Analyses
In the model we use three different parameter types (Table
1): (1) ﬁxed parameters that have the same value in all
simulations; (2) uncertain parameters that we vary in an
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to study different scenarios.
Fixed parameters. We simulate a period of at least 80 d to
cover the length of a typical national inﬂuenza epidemic. If
there are still infected individuals in the department after 80
d, the simulation is continued until no infected individuals
are left. We take time steps of 8 h, equal to the length of a
HCW’s shift. The patients’ average length of stay in the
department is 14 mo [13,14]. The durations of the latent and
infectious periods are exponentially distributed with means
of 1.4 d such that the resulting generation time equals 2.8 d,
which is in agreement with observations of generation times
during inﬂuenza epidemics [15,16]. At the start of the
inﬂuenza season, 30% of the adult population is assumed to
be immune to infection due to cross protection from earlier
infections (see also Text S1) [17,18]. The elderly however have
a weakened immune system [19,20] and thus we assume
absence of immunological memory of previous infections. In
correspondence with a recently published HCW vaccination
trial, on average 75% of the nursing home patients have been
vaccinated [4].
The contact rates between HCWs and patients are based on
observations of contact behavior in nursing homes. We
determine the probability of contact between two individuals
given their type (HCW or patient) as well as the probability
that this contact is a close contact (involving physical contact)
(Text S1 [Tables III–V]). During their working shift, the
probability that a speciﬁc HCW contacts a speciﬁc patient is
0.52; the probability that such a contact is a close contact is
0.69. The probability that a speciﬁc HCW at work contacts
another HCW on the same shift is 0.91, and the probability
that this contact is close is 0.31. HCWs do not contact visitors
in the department. The probability that a speciﬁc patient
contacts a speciﬁc HCW at work is consistent with the contact
behavior of HCWs as described above. The probability that a
speciﬁc patient contacts another speciﬁc patient is 0.13
during the day and evening shifts, and these contacts are close
with a probability of 0.06. During the night shift, patients
contact their room mate, which is assumed to be a casual
contact. During the day and evening shifts, patients can also
contact visitors. All contacts with visitors are close.
Uncertain parameters. Uncertainty in parameters is
handled by Latin hypercube sampling as was ﬁrst introduced
by McKay et al. [21] and subsequently used for disease
transmission models by Blower et al. [22–25]. For the
parameters patient vaccine efﬁcacy, HCW vaccine efﬁcacy,
transmission probability, and visitor frequency, we choose a
likely range for the parameter values (see Table 1) and draw
actual values from a uniform distribution over this range. For
every scenario under study we make 50 different parameter
sets such that the whole range of possible values for each of
the four parameters is represented equally.
Vaccine efﬁcacy for healthy adults was estimated as 73%
(95% conﬁdence interval (CI) 53%–84%), and therefore we
use a range of values between 50% and 90% [26]. For elderly
nursing home patients the observed vaccine efﬁcacy against
inﬂuenza virus infection was not signiﬁcantly different from
zero [27]. However, as other evidence shows that the vaccine
protects against inﬂuenza illness and complications [27,28] we
assume patient efﬁcacy to be between 0% and 50%.
Since no data are available on the probability of trans-
mission for a given contact, we varied the transmission
probability parameter and determined the resulting infection
attack rates. We choose the transmission probability to be
between 0.1 and 0.15 for a casual contact (per shift), such that
the expected infection attack rate among patients in the
absence of HCW vaccination is 23%, corresponding to
observed inﬂuenza-like-illness attack rates in a moderate
inﬂuenza season [4,29]. The probability of transmission for
close contacts is twice as large as for casual contacts. Varying
Table 1. Parameter Values
Parameter Type Description Value Unity Reference
Fixed Number of beds (n) 30 — —
Number of HCWs 30 — —
Time step (¼shift) 8h —
Minimum duration of simulation 80 d —
Discharge/mortality rate 1/425 d
 1 [13,14]
Rate of becoming infectious after infection 1/1.4 d
 1 [15,16]
Infection recovery rate 1/1.4 d
 1 [15,16]
Fraction of HCWs immune due to through cross-protection 0.3 — [17,18]
Vaccine uptake patients 0.75 — [4]
Probability of contact between patient–patient 0.07 shift
 1 —
Probability of contact between HCW–patient 0.52 shift
 1 —
Probability of contact between HCW–HCW 0.91 shift
 1 —
Probability of close contact between
patient–patient
0.06 contact
 1 —
Probability of close contact between HCW–patient 0.69 contact
 1 —
Probability of close contact between HCW–HCW 0.32 contact
 1 —
Close/casual transmission probability ratio (p1/p2) 2— —
Uncertain Vaccine efficacy (against infection) for patients (ve1) 0.25 (0–0.5) — [27]
Vaccine efficacy (against infection) for HCWs (ve2) 0.73 (0.5–0.9) — [26]
Transmission probability casual contact (p1) 0.13 (0.1–0.16) contact
 1 —
Average number of visitors 0.7 (0.4–1.0) patient
 1 d
 1 [30]
Control Vaccine uptake HCWs 0–1.0 — —
doi:10.1371/journal.pmed.0050200.t001
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Text S1 (Figure X). The expected number of visitors was
estimated from a Dutch study on nursing home patients and
visitors to be between 0.4 and 1.0 patient
 1 day
 1 [30].
To assess the variation in outcome due to stochasticity in
the transmission process, we perform simulations with a
single, default, parameter set (vaccine efﬁcacy HCWs 73%,
vaccine efﬁcacy patients 25%, transmission probability 0.13,
and the expected number of visitors 0.7, see Text S1) and
compare the resulting variance with the one from the baseline
simulation that uses the whole described parameter space.
Control parameters. Simulations are performed for rates of
HCW vaccine uptake of 0, 0.25, 0.5, 0.75, and 1. In addition to a
baseline scenario with a nursing home where patients can
contact other patients, HCWs, and visitors, as described above
(parameters as in Table 1), we study three different scenarios;
(1) extreme scenarios of either a closed department, where
patients cannot receive visitors and thus only contact other
patients and HCWs, or an open department, where patients
are assumed to have many contacts (also outside the nursing
home) and, therefore, have the same probability of being
infected as people in the community; (2) variations in HCW/
patient ratios from 1 in the baseline scenario, consistent with
our nursing home observations, to 1.5, and 0.67. In these
simulations the number of HCWs is varied while the number
of patients remains the same; (3) seasons with high and low
inﬂuenza virus activity simulated with community epidemic
curves with total attack rates of 5% and 15%, respectively, as
compared to 10% in the baseline scenario.
In addition to the most plausible scenarios described here,
we show simulations for some other scenarios in Text S1: a
60-bed nursing home department (Text S1 [Figure VI]);
higher levels of immunity due to cross protection among
HCWs (Text S1 [Figure VII]); a pandemic strain (Text S1
[Figure VIII]); an alternative mechanism of vaccine protec-
tion (Text S1 [Figure IX]); other infectiousness ratio between
casual and close contacts (Text S1 [Figure X]); and a high
vaccine efﬁcacy for patients and HCWs (Text S1 [Figure XI]).
Outcome
We study the relationship between the HCW vaccination
rate and the fraction of patients that gets an inﬂuenza virus
infection during the inﬂuenza season. The patient attack rate
is deﬁned as the total number of infections among patients
divided by the total number of patients in the department
during the study period. For every level of HCW vaccine
uptake we perform 5,000 simulations (100 simulations 3 50
parameter sets) of one nursing home department during one
inﬂuenza season. We compute the arithmetic mean and
median of infection attack rates among patients, the standard
error of the mean, the range between 2.5-percentile and 97.5-
percentile, and the proportion of infection attack rates of 0.3
or larger that we use as a proxy for the probability of a large
outbreak. In addition to patient attack rates, we calculate the
mean HCW attack rate, the mean number of introductions of
inﬂuenza virus into the nursing home patient population
(introduction rate), and the mean number of infections
among patients following an introduction (patient attack rate
per introduction). Finally, we calculate the absolute and
relative risk differences of acquiring inﬂuenza virus infection
for patients in departments where none or all of the HCWs
are vaccinated.
Herd Immunity
The concept of herd immunity has not been deﬁned for a
small population. In contrast to large populations, multiple
introductions (with no or little transmission) in the nursing
home can already affect a considerable fraction of the
population, albeit still few patients. The distinction between
these small outbreaks and larger outbreaks caused by
substantial virus transmission is not always clear. In this
study we use the absence (probability , 0.05) of large
outbreaks (infection attack rate . 0.3) as a proxy for herd
immunity.
Power Analysis
To determine the number of departments needed for a
trial to detect a difference between average HCW vaccination
rates of 0 and 0.5, we use the power calculation for cluster
randomized trials introduced by Kerry et al. [4,31] that is
based on conventional power calculations [32]. We checked
the accuracy of this equation using a simulation approach,
see Text S1. When we use a signiﬁcance level (a) of 5% and a
power (1 b) of 90% the number of departments required for
each group is: n ¼ 21(sc
2 þ p(1   p)/m)/d
2, where sc
2 is the
between department variance and p(1   p)/m the within
department variance, p the fraction of individuals in the
department with the outcome, m the number of individuals
per department, and d the expected difference between the
two groups.
Results
Baseline Scenario
An increase in HCW vaccine uptake decreases the expected
inﬂuenza virus attack rate among nursing home patients
(Figure 1). The relationship between the fraction of HCWs
vaccinated and the mean patient attack rate appears linear.
In the baseline scenario, with the parameter values as shown
in Table 1, increasing HCW vaccination rate from 0 to 1
decreases the patient attack rate from 0.25 to 0.10, a risk
difference of 0.15 (Figure 1A). Thus, approximately 60% of
the patients that would have been infected without HCW
vaccination are protected when all HCWs are vaccinated
(relative risk 0.41), and seven HCWs have to be vaccinated to
protect one patient from inﬂuenza virus infection. This NNT
(number needed to treat) does not change with increasing
vaccine uptake by HCWs, and no herd immunity is reached.
The fraction of departments without infections among
patients increases from 0.30 to 0.48, whereas the fraction of
departments with a large epidemic (attack rates of more than
0.3) decreases from 0.41 to 0.14. Thus there is no evidence of
herd immunity.
In the absence of HCW vaccination, the distribution of
patient attack rates is bimodal, with peaks around attack rates
of 0 and 0.6 (Figure 1B). With higher HCW vaccine coverage,
mean and median patient attack rates decrease (Figure 1A),
and the second peak disappears (Figure 1C and 1D). Due to
stochastic variations the differences between patient attack
rates are high and major outbreaks can occur at all levels of
HCW vaccine uptake. The small standard error of the mean
(, 0.0013 for all levels of HCW vaccine uptake) shows that we
perform a sufﬁcient number of simulations to obtain precise
estimates of the mean, hence the observed variation is not
due to sampling error. Additional simulations show that most
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transmission process rather than parameter uncertainty
(Text S1 [Figure II]; therefore these additional simulations
justify the use of the mean and percentiles from the Latin
hypercube parameter samples to illustrate the effect of HCW
vaccine uptake on attack rate among patients in Figure 1). In
a parameter uncertainty analysis the visitor frequency
appears to have less impact on the attack rates among
patients than the vaccine efﬁcacies and the transmission
probability (Text S1 [Figures IV and V]).
The effect of increased HCW vaccination on patient
inﬂuenza virus attack rate can be attributed to a decrease
in the number of introductions of inﬂuenza virus into the
patient population as well as a decrease in the number of
infections among patients following such an introduction
(Figure 2). Both reductions are caused by a decreased number
of inﬂuenza virus infections among HCWs (Figure 2).
Scenario Analyses
In the scenarios with an open and closed department the
absolute change in the expected patient attack rate is similar
to that in the baseline scenario (Figure 3A). The relative
change caused by an increase in HCW vaccination rate from 0
to 1 is highest for the closed department (73%). Also in
scenarios with higher and lower inﬂuenza virus activity, the
decrease in patient attack rate upon increased vaccination of
HCW is approximately linear (Figure 3B). The absolute
decrease in patient attack rate is highest in the season with
high inﬂuenza activity (0.19), but the relative decrease is lower
than that in the baseline scenario (50%). In scenarios with
other HCW/patient ratios (1.5 and 0.67, respectively), the
fraction of HCWs that has to be vaccinated to protect one
patient is similar to what we observed in the baseline scenario
(Figure 3C). The absolute number of HCWs to be vaccinated
is however different (11 and ﬁve, respectively). Simulations
for a 60-bed department, alternative vaccine efﬁcacy mech-
anism, and some more parameter variations also give
qualitatively similar results (Text S1 [Figure VI]). In case of
pandemic inﬂuenza, with full absence of immunity in the
population, we analyze a best case scenario in which we
assume that a vaccine is available with equal efﬁcacy as the
vaccines for seasonal strains. Without vaccination of HCWs,
in this scenario, major outbreaks occur in all departments
with an average patient attack rate of 0.59. When the HCW
vaccination rate is increased to 1, the patient attack rate
decreases to 0.37, but large outbreaks still prevail (Text S1
[Figure VIII]).
Power Analyses
A power calculation for cluster randomized trials using the
effect estimates and variances of the simulations with the
default parameter set (see Text S1) reveals the need of 184
departments per arm to allow detection of a statistically
signiﬁcant difference (a¼5%) in patient attack rates between
departments with HCW vaccination rates of 0 and 0.5 with a
90% power (Text S1 [Figure III]). With a simulation approach
we ﬁnd a need of 169 departments to detect such a difference
at the 5% level with 90% power. In both power calculations
we do not take into account variation due to differences
between departments (e.g., size, HCW/patient ratios, health
state of patients), inﬂuenza seasons, and vaccine matching,
which would further increase the number of departments
required.
Discussion
Our model reveals a linear relationship between the
number of HCWs vaccinated and the expected number of
inﬂuenza virus infections among patients in a nursing home
department. No threshold for herd immunity can be detected
and even when HCW vaccine uptake is maximal, due to
stochastic effects that are inherent to the transmission
process, the variation in patient attack rates is high and
large outbreaks can occur. In fact, the value of small-sized
clinical trials in estimating the protective effect of HCW
vaccination on patient outcome seems questionable due to
Figure 1. Influenza Virus Attack Rates among Patients for Increasing Health Care Worker Vaccination Rates
(A) Increased vaccination of HCWs decreases the expected influenza virus attack rate among patients. Squares indicate the mean attack rates, dashed
lines the median attack rates, and light blue boxes the 2.5th to 97.5th percentiles.
(B–D) The distribution of the influenza virus attack rates among patients shifts to the left when vaccine uptake among HCWs is increased from 0, to 0.5,
and 1 for (B), (C), and (D), respectively. Each distribution is based on 5,000 simulations.
doi:10.1371/journal.pmed.0050200.g001
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ment of nursing home departments.
In order to appreciate the results of our modeling study
some possible limitations need to be addressed. First, we
assume that all individuals in the model, whether patient,
HCW, or visitor are equally infectious or susceptible. In
addition, all individuals from the same group are assumed to
have similar contact probabilities. Both assumptions decrease
the heterogeneity in the system, which might have slightly
increased the probability of a major outbreak [12]. Second,
we model the nursing home department as an independent
institute and neglect its potential connections with other
departments. In fact, within a nursing home some of the
introductions of inﬂuenza virus in a department may come
from another department. Vaccination of HCWs in all
departments reduces the transmission risk in each of them,
and, thus, provides indirect protection. Therefore, the
protective effect of HCW vaccination per given vaccine will
be higher on the level of an entire nursing home, which might
have led to an underestimation of the impact of HCW
inﬂuenza vaccination. Third, we only consider departments
of 30 beds. However, simulations of larger nursing home
departments (see Text S1 [Figure VI]) reveal that department
size has little impact on the qualitative results. Fourth, the
simulated infection attack rates only give an approximate
indication of the corresponding inﬂuenza-like illness (ILI)
attack rates. To convert infection attack rates to ILI attack
rates, we use two empirical ﬁndings: inﬂuenza virus infection
leads to illness in approximately 50% of the cases [33];
approximately 50% of observed ILIs is caused by inﬂuenza
virus infection [34,35]. Taken together, the inﬂuenza virus
attack rate roughly approximates the observed ILI attack rate.
To our knowledge our model is the ﬁrst to explore the
effect of HCW vaccination on the occurrence of inﬂuenza
virus infections in nursing home patients. The major
advantage of our model over previously performed exper-
imental and observational studies [3–5,36,37] is the possibility
to simulate various levels of HCW vaccine uptake and
perform multiple simulations to minimize the inﬂuence of
chance effects. Therefore, it can be used to reinterpret the
outcome of small-scale clinical trials. We ﬁnd very wide
distributions of patient attack rates that agree with reported
differences in outbreak sizes and attack rates between
departments and seasons [29]. Also due to the diversity in
outcomes, all available data on attack rates in nursing homes
are in line with our simulation results. Our model suggests
that for plausible regions in the parameter space there is no
herd immunity threshold above which all patients are
Figure 2. Effects of Increased Health Care Worker Vaccination on Influenza Virus Attack and Introduction Rates
Increased vaccination of health care workers (HCWs) reduces the influenza virus attack rate among HCWs. It also reduces the rate of introduction of
influenza virus into the patient population and the attack rate among patients following an introduction. As a consequence it reduces the total attack
rate among patients. All relationships appear linear.
doi:10.1371/journal.pmed.0050200.g002
Figure 3. Effects of Increased Health Care Worker Vaccination on Patient Attack Rates in Different Scenarios
For all scenarios under study, the influenza virus attack rate among patient decreases in an approximately linear way when the health care worker
vaccination rate is increased.
(A) The expected attack rates for the open and closed departments, where patients have many or no contacts with individuals from the community,
respectively.
(B) The attack rates for seasons with high (15% community attack rate) and low (5% community attack rate) influenza virus activity.
(C) The attack rates for departments with high and low HCW/patient ratios.
doi:10.1371/journal.pmed.0050200.g003
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Modeling HCW Vaccinationprotected as was hypothesized before [10,38]. To the contrary,
every additional HCW vaccination protects an additional
fraction of patients and therefore increasing HCW vaccina-
tion rate from 0.8 to 0.9 is as important as increasing it from
0.1 to 0.2. Consequently, if HCW vaccination is adopted as a
policy, beneﬁts are to be expected for every additional
vaccination as long as 100% coverage is not achieved. The
unexpected absence of herd immunity for nursing home
populations can be explained by two facts. First, due to the
low efﬁcacy of the inﬂuenza vaccine, especially among the
elderly, the fraction of susceptible individuals remains
substantial even with high vaccination rates. Second, the
nursing home department is not a large closed population,
for which the concept of herd immunity has been established.
Instead it is a small population with many links, through
HCWs and visitors, to a larger community where an inﬂuenza
epidemic is ongoing.
Our study further demonstrates the large impact of
stochastic events on patient attack rates, which is of
immediate concern for both the interpretation of previously
performed HCW vaccination trials and the design of future
experimental studies. A power calculation for cluster
randomized trials (a ¼ 0.05, b ¼ 0.10) [31] in which we use
the variances and effect estimates obtained from 5,000
simulations with one parameter set, reveals the need of 184
departments per arm to detect a signiﬁcant difference in
patient attack rates between departments with HCW vacci-
nation rates of 0 and 0.5. This suggests that the previously
performed trials on HCW vaccination, with six to 23
departments per arm [3–5], were underpowered and cannot
be assumed to give a precise effect estimate of HCW
vaccination. The difference between the small conﬁdence
intervals around the effect estimates in these studies and the
large variance predicted by our model, might be explained by
a difference between the measured sample variance and the
true population variance. With small sample sizes, the sample
variance can deviate substantially from the population
variance [39]. Moreover, the performed trials were based on
secondary endpoints such as ILI, inﬂuenza-related hospital
admissions, or (all cause) mortality rather than inﬂuenza
infection, which further reduces their power, since these
endpoints occur less often than inﬂuenza infection and the
difference between control and intervention groups is
expected to be smaller. These ﬁndings should be taken into
account when designing future studies to demonstrate the
generally presumed beneﬁt of HCW vaccination.
Supporting Information
Text S1. Detailed Description of Mathematical Model
Found at doi:10.1371/journal.pmed.0050200.sd001 (1.2 MB DOC).
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Editors’ Summary
Background. Every winter, millions of people catch influenza, a
contagious viral disease of the nose, throat, and airways. Most people
recover completely from influenza within a week or two but some
develop life-threatening complications such as bacterial pneumonia. As a
result, influenza outbreaks kill about half a million people—mainly
infants, elderly people, and chronically ill individuals—each year. To
minimize influenza-related deaths, the World Health Organization
recommends that vulnerable people be vaccinated against influenza
every autumn. Annual vaccination is necessary because flu viruses
continually make small changes to the viral proteins (antigens) that the
immune system recognizes. This means that an immune response
produced one year provides only partial protection against influenza the
next year. To provide maximum protection against influenza, each year’s
vaccine contains disabled versions of the major circulating strains of
influenza viruses.
Why Was This Study Done? Most Western countries also recommend
annual flu vaccination for health care workers (HCWs) in hospitals and
other institutions to reduce the transmission of influenza to vulnerable
patients. However, many HCWs don’t get a regular flu shot, so should
efforts be made to increase their rate of vaccine uptake? To answer this
question, public-health experts need to know more about the relation-
ship between vaccine uptake among HCWs and patient protection. In
particular, they need to know whether a high rate of vaccine uptake by
HCWs will provide ‘‘herd immunity.’’ Herd immunity occurs because,
when a sufficient fraction of a population is immune to a disease that
passes from person to person, infected people rarely come into contact
with susceptible people, which means that both vaccinated and
unvaccinated people are protected from the disease. In this study, the
researchers develop a mathematical model to investigate the relation-
ship between vaccine uptake among HCWs and patient protection in a
nursing home department.
What Did the Researchers Do and Find? To predict influenza virus
attack rates (the number of patient infections divided by the number of
patients in a nursing home department during an influenza season) at
different levels of HCW vaccine uptake, the researchers develop a
stochastic transmission model to simulate epidemics on a computer. This
model predicts that as the HCW vaccination rate increases from 0 (no
HCWs vaccinated) to 1 (all the HCWs vaccinated), the expected average
influenza virus attack rate decreases at a constant rate. In the researchers’
baseline scenario—a nursing home department with 30 beds where
patients come into contact with other patients, HCWs, and visitors—the
model predicts that about 60% of the patients who would have been
infected if no HCWs had been vaccinated are protected when all the
HCWs are vaccinated, and that seven HCWs would have to be vaccinated
to protect one patient. This last figure does not change with increasing
vaccine uptake, which indicates that there is no level of HCW vaccination
that completely stops the spread of influenza among the patients; that is,
there is no herd immunity. Finally, the researchers show that large
influenza outbreaks can happen by chance at every level of HCW vaccine
uptake.
What Do These Findings Mean? As with all mathematical models, the
accuracy of these predictions may depend on the specific assumptions
built into the model. Therefore the researchers verified that their findings
hold for a wide range of plausible assumptions. These findings have two
important practical implications. First, the direct relationship between
HCW vaccination and patient protection and the lack of any herd
immunity suggest that any increase in HCW vaccine uptake will be
beneficial to patients in nursing homes. That is, increasing the HCW
vaccination rate from 80% to 90% is likely to be as important as
increasing it from 10% to 20%. Second, even 100% HCW vaccination
cannot guarantee that influenza outbreaks will not occasionally occur in
nursing homes. Because of the large variation in attack rates, the results
of small clinical trials on the effects of HCW vaccination may be
inaccurate and future studies will need to be very large if they are to
provide reliable estimates of the amount of protection that HCW
vaccination provides to vulnerable patients.
Additional Information. Please access these Web sites via the online
version of this summary at http://dx.doi.org/10.1371/journal.pmed.
0050200.
  Read the related PLoS Medicine Perspective by Ce ´cile Viboud and Mark
Miller
  A related PLoS Medicine Research Article by Jeffrey Kwong and
colleagues is also available
  The World Health Organization provides information on influenza and
on influenza vaccines (in several languages)
  The US Centers for Disease Control and Prevention provide informa-
tion for patients and professionals on all aspects of influenza (in
English and Spanish)
  The UK Health Protection Agency also provides information on
influenza
  MedlinePlus provides a list of links to other information about
influenza (in English and Spanish)
  The UK National Health Service provides information about herd
immunity, including a simple explanatory animation
  The European Centre for Disease Prevention and Control provides an
overview on the types of influenza
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